SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US
November 27 2023 - 2:00AM
Business Wire
A revolutionary at-home 12-lead ECG service with 24/7
cardiologist review and telehealth service.
SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL”
or the “Company”), a leading provider and developer of
advanced personal telemedicine solutions is pleased to announce the
soft launch of the SmartHeart® membership program in the US,
marking a significant step forward in at-home healthcare. This
program, available at www.getsmartheart.com, is part of SHL's
Direct-to-Consumer (D2C) initiative, offering a comprehensive
subscription service that delivers at home professional cardiac
care directly to the consumer.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231126806466/en/
(Photo: Business Wire)
The SmartHeart® membership program is designed to revolutionize
home-based access to cardiac care. It includes the innovative,
user-friendly SmartHeart® portable 12-lead ECG device, offering
round-the-clock interpretation by board-certified cardiologists and
on-demand telehealth visits. This initiative not only simplifies
the process of conducting a full 12-lead ECG at home but also
ensures convenient and dependable heart health management, meeting
the evolving needs of today's healthcare consumers.
The SmartHeart® Membership Offers to the subscribing
members:
- Portable 12-lead ECG device: The SmartHeart® ECG, a
cutting-edge and user-friendly device, enables high-quality 12-lead
ECG performance anytime and anywhere.
- 24/7 cardiologist interpretation: Subscribers receive
access to expert analysis of their ECG by board-certified
cardiologists, offering peace of mind and prompt response to
cardiac related symptoms.
- On-demand telehealth visits: This feature provides
convenient access to medical professionals for consultations,
enabling timely and informed health decisions.
- Flexible subscription plans: SmartHeart® offers a
variety of private-pay subscription options, each tailored to
individual needs, ensuring affordable access to state-of-the-art
cardiac care.
“This service transcends mere technological innovation; it
represents a significant advancement in delivering care and
reassurance into the lives of individuals, transforming access to
cardiac care, making it less daunting and more approachable for
all,” explained Erez Nachtomy, CEO of SHL Telemedicine, adding:
“This approach makes SmartHeart® an ideal solution not only for
those at risk or living with chronic heart conditions but also for
the elderly and anyone proactive about managing their heart
health.”
For detailed information on subscription options, availability
of the SmartHeart® Membership program in different States as well
as customer testimonials, please visit our website at
www.getsmartheart.com
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal
telemedicine systems and the provision of medical call center
services, with a focus on cardiovascular and related diseases, to
end users and to the healthcare community. SHL Telemedicine offers
its services and personal telemedicine devices to subscribers
utilizing telephonic and Internet communication technology. SHL is
listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885,
Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT,
ISIN: US78423T2006, CUSIP: 78423T200).
For more information, please visit our website at
www.shl-telemedicine.com.
Forward-Looking Statements
Some of the information contained in this press release contains
forward-looking statements. Readers are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those in the forward-looking statements as a
result of various factors. SHL Telemedicine undertakes no
obligation to publicly update or revise any forward-looking
statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231126806466/en/
Fabienne Farner, IRF, Phone : +41 43 244 81 42,
farner@irf-reputation.ch
SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From Jan 2025 to Feb 2025
SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From Feb 2024 to Feb 2025